Cite
Cetani F, Banti C, Pardi E, et al. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect. 2013;2(4):186-95doi: 10.1530/EC-13-0046.
Cetani, F., Banti, C., Pardi, E., Borsari, S., Viacava, P., Miccoli, P., Torregrossa, L., Basolo, F., Pelizzo, M. R., Rugge, M., Pennelli, G., Gasparri, G., Papotti, M., Volante, M., Vignali, E., Saponaro, F., & Marcocci, C. (2013). CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocrine connections, 2(4), 186-95. https://doi.org/10.1530/EC-13-0046
Cetani, Filomena, et al. "CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer." Endocrine connections vol. 2,4 (2013): 186-95. doi: https://doi.org/10.1530/EC-13-0046
Cetani F, Banti C, Pardi E, Borsari S, Viacava P, Miccoli P, Torregrossa L, Basolo F, Pelizzo MR, Rugge M, Pennelli G, Gasparri G, Papotti M, Volante M, Vignali E, Saponaro F, Marcocci C. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect. 2013 Oct 28;2(4):186-95. doi: 10.1530/EC-13-0046. Print 2013. PMID: 24145611; PMCID: PMC3847926.
Copy
Download .nbib